INTRODUCTION AND OBJECTIVES: Continent cutaneous diversion (CCD) is a less commonly utilized diversion choice following open or robotic cystectomy. We have previously described a novel technique for robotic intracorporeal CCD. Meanwhile, continent cutaneous augmentation cystoplasty (CCAC) is a viable option for patients with neurogenic bladder. There is limited worldwide experience performing intracorporeal CCD and no studies describing intracorporeal CCAC. Principles developed in robotic CCD can be readily applied to robotic CCAC. We share our experience with these novel robotic procedures.
INTRODUCTION AND OBJECTIVES: Continent cutaneous diversion (CCD) is a less commonly utilized diversion choice following open or robotic cystectomy. We have previously described a novel technique for robotic intracorporeal CCD. Meanwhile, continent cutaneous augmentation cystoplasty (CCAC) is a viable option for patients with neurogenic bladder. There is limited worldwide experience performing intracorporeal CCD and no studies describing intracorporeal CCAC. Principles developed in robotic CCD can be readily applied to robotic CCAC. We share our experience with these novel robotic procedures.
METHODS: Robotic cystectomy was performed in patients undergoing CCD using a standard 6-port technique. The patient and robot were then repositioned for intracorporeal bowel mobilization and segmentation, ileocolonic anastomosis, uretero-colonic anastomoses, pouch construction, tapering of catheterization channel, reinforcement of ileocecal valve, and stoma creation. All patients were placed on an evidencebased Enhanced Recovery after Surgery protocol postoperatively. Operative times, intraoperative blood loss (EBL), length of stay (LOS), and complications occurring within 90 days of surgery were reviewed.
RESULTS: Ten robotic intracorporeal right colon urinary diversions, including four robotic intracorporeal CCAC and six robotic intracorporeal CCD, were performed. Mean total operative times for cystectomy and intracorporeal urinary diversion were 7.8 and 10 hours for CCAC or CCD respectively (5.4-9.5; 7.9-12.9). Mean EBL was 181ml (75-300) for CCAC and 250ml (100-500) for CCD. Mean LOS for CCAC and CCD groups was 10 and 8.8 days respectively (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . A single CCAC patient required transfusion postoperatively. Two high grade complications (Clavien III or greater) were reported in the CCAC group (50%). One high grade complication was reported in the CCD group (17%). Within 30 days of surgery, no CCAC and two CCD patients required readmission (0%, 33%). With a median follow up of 17 months, no incontinence was reported and all patients were able to catheterize without difficulty.
CONCLUSIONS: We demonstrate that robotic intracorporeal CCD and CCAC are technically feasible and safe with good functional outcomes. Further evaluation of these novel surgical techniques along with comparative studies are needed.
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PD38-08 DOES THE USE OF RECREATIONAL KETAMINE POSE A CHALLENGE ON BLADDER RECONSTRUCTIVE SURGERY?
Neha Sihra*, Simon Rajendran, Jeremy Ockrim, Dan Wood, London, United Kingdom INTRODUCTION AND OBJECTIVES: Regular use of recreational ketamine causes severe damage to the urinary tract. Patients present with a spectrum of debilitating symptoms including pain, urinary frequency, haematuria and renal failure. The aim of this study was to evaluate management strategies and outcomes in patients undergoing surgical intervention following damage to their urinary tract associated with ketamine use.
METHODS: A retrospective review of prospectively collected data between 2007 and 2015 was performed. Evaluation included CT urogram, cystoscopic evaluation of bladder capacity þ/biopsy. Indications and outcomes for surgical intervention were assessed.
RESULTS: 42 patients were identified. 63% were male and mean age at presentation was 28.7 (range 23-55). All bladder biopsies confirmed an eosinophilic inflammatory infiltrate. A significant proportion of patients (83.3%) were found to have reduced cystoscopic and functional bladder capacity of <300 ml (mean 190 mls, range 70-550). 29 patients were treated conservatively with a view to symptom resolution. 2 patients underwent dilatation for urethral strictures. 4 patients underwent repeated intra-detrusor onabotulinum toxin injection with minimal subjective symptom relief. 2 of these patients proceeded to have major reconstruction.13 patients underwent reconstruction which included simple cystectomy (5/13), substitution cystoplasty (6/13), augmentation cystoplasty (6/13), ileal conduit diversion (1/13), ureteric interposition using ileum (2/13) and appendix Mitrofanoff formation (6/ 13). Of these patients 53.8% (7/13) had one or more complications requiring additional intervention Complications included urine leak (1/7), anastomotic leak (2/7), adhesional small bowel obstruction (1/7), wound necrosis (1/7), ureteric stricture (3/7) and Mitrofanoff stenosis (1/7). One patient was lost to follow up and there was 1 death from pneumonia 5 years following and unrelated to surgery.
CONCLUSIONS: In a tertiary, high volume reconstructive unit we found ketamine patients seemed to be at particular risk of significant peri-operative complications. There did not appear to be any other common factor apart from their use of ketamine and the significant inflammatory change associated with its misuse. We therefore recommend meticulous pre-operative evaluation and multidisciplinary consultation for all patients to determine optimal treatment strategies prior to undertaking major bladder reconstructive surgery. . 197, No. 4S, Supplement, Sunday, May 14, 2017 
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